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ABSTRACT
The regulation of T cell and DC retention and lymphatic
egress within and from the intestine is critical for in-
testinal immunosurveillance; however, the cellular pro-
cesses that orchestrate this balance during IBD remain
poorly defined. With the use of a mouse model of
TNF-driven Crohn’s-like ileitis (TNFDARE), we examined
the role of CCR7 in the control of intestinal T cell
and DC retention/egress during experimental CD. We
observed that the frequency of CCR7-expressing
TH1/TH17 effector lymphocytes increased during active
disease in TNFDARE mice and that DARE/CCR72/2 mice
developed exacerbated ileitis and multiorgan inflam-
mation, with a marked polarization and ileal retention of
TH1 effector CD4
+ T cells. Furthermore, adoptive trans-
fer of DARE/CCR72/2 effector CD4+ into lymphopenic
hosts resulted in ileo-colitis, whereas those transferred
with DARE/CCR7+/+ CD4+ T cells developed ileitis.
DARE/CCR72/2 mice had an acellular draining MLN,
decreased CD103+ DC, and decreased expression of
RALDH enzymes and of CD4+CD25+FoxP3+ Tregs.
Lastly, a mAb against CCR7 exacerbated ileitis in
TNFDARE mice, phenocopying the effects of congenital
CCR7 deficiency. Our data underscore a critical
role for the lymphoid chemokine receptor CCR7 in
orchestrating immune cell traffic and TH1 versus TH17
bias during chronic murine ileitis. J. Leukoc. Biol.
97: 1011–1022; 2015.
Introduction
Intestinal immune homeostasis is reliant on maintaining
tolerance to food and bacterial antigens while remaining poised
to respond to intestinal pathogens. Most lymphocytes within the
GALT constantly traffic from blood into tissues, where they may
become resident or recirculate through the mesenteric lym-
phatics back to the circulation. This process allows for the
dynamic cellular encounters of antigen-presenting DCs and naı¨ve
T cells that shape protective adaptive immunity. Whereas the
recirculation of T cells is critical for immunosurveillance, a clear
role for TH1/TH17 CD4
+ TEM subsets in the LP has been
implicated in driving the pathogenesis of CD [1–3]. The
understanding of the control of cellular recruitment, tissue
retention, and egress is critical for the development of novel,
therapeutic modalities that target traffic in IBD. However to date,
whereas we have been able to therapeutically harness some of the
molecules that determine intestinal recruitment (i.e., integrins
a4 and a4b7), those that control intestinal retention and
lymphatic egress of gut-tropic T cell subsets are less defined.
The chemokine receptor CCR7 was originally believed to be
expressed only by activated DCs and naı¨ve T cells, limiting the role
of this receptor for homing to lymph nodes. Later, seminal
observations demonstrated that CCR7 was re-expressed by activated
T cells, allowing their egress from tissues to lymph nodes via afferent
lymphatics [4–6]. The expression of CCR7 ligands, CCL19 and
CCL21, is tightly regulated within lymphoid organs, acting as
chemotactic and retentive signals [7, 8]. However, increased ectopic
expression of CCL19 and CCL21 has been reported in the inflamed
intestine of patients with CD and in preclinical models of chronic
ileitis [9, 10], yet the role of their cognate receptor CCR7 in
regulating TEM recirculation during conditions of chronic in-
flammation is less understood.
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Here, we use the TNFΔARE mouse model of chronic Crohn’s-
like ileitis [11], which develops terminal ileitis reminiscent of
human CD, to assess the contribution of the CCR7 chemokine
axis to disease pathogenesis. We investigated the expression of
CCR7 on cytokine-producing effector T cell subsets infiltrating
the ileum and MLN during disease onset. Furthermore, we
generated a DARE/CCR72/2 substrain and assessed the effects
of CCR7 deficiency on disease severity, T cell phenotype, and
cytokine production. After the identification of an exacerbation
of disease in DARE/CCR72/2 mice compared with CCR7-
sufficient counterparts, we further defined a role for CCR7 in the
intestinal retention of CD4+ TEM by use of T cell adoptive transfer
and immunoneutralization studies.
MATERIALS AND METHODS
Mice
The B6.129S-Tnftm2Gkl/Jarn (TNFΔARE) strain was described previously.
These mice overproduce TNF and develop CD-like ileitis and arthritis
[9, 11]. CCR7-deficient [B6.129P2(C)-Ccr7
tm1Rfor/J] and RAG12/2 mice
(B6.129S7-Rag1tm1Mom/J) were purchased from The Jackson Laboratory
(Bar Harbor, ME, USA). To generate a CCR7-deficient substrain, TNFΔARE
mice were backcrossed to B6.129P2(C)-Ccr7
tm1Rfor/J. Experimental mice
used were heterozygous for the DARE mutation, homozygous for CCR7
deficiency, or CCR7 sufficient. Mice were kept under specific pathogen-free
conditions, and fecal samples were negative for Helicobacter species, protozoa,
and helminthes. Animal procedures were approved by the Institutional
Animal Care and Use Committees of the University of Colorado Denver
and University of California, San Diego.
Tissue fixation, paraffin embedding, and
histologic scoring
Terminal ilea were excised, opened longitudinally, and washed with cold PBS,
followed by fixation with 10% buffered formalin. Tissue was subsequently
paraffin embedded, cut into 5 mm sections, and stained with H&E. Histologic
assessment of ileitis was performed in a blinded fashion by an intestinal
pathologist, as described [12].
RNA extraction, cDNA synthesis, and real-time PCR
Total RNA was isolated from homogenized ilea or MLN by use of the RNeasy
Mini Kit (Qiagen, Valencia, CA, USA). RNA (500 ng) was reverse transcribed
into cDNA with a high-capacity cDNA archive kit (Applied Biosystems, Foster
City, CA, USA). Real-time RT-PCR was performed by use of TaqMan gene
expression assays (Applied Biosystems) containing forward and reverse
primers and a FAM-labeled Minor Groove Binder (MGB) TaqMan probes.
PCR assays for IFN-g (Mm00801778_m1), TNF (Mm00443258_m1), IL-1b
(Mm00434228_m1), IL-6 (Mm00446191_m1), IL-12p35 (Mm00434165_m1),
IL-12p40 (Mm_00434174_m1), IL-23 (Mm00518984_m1), IL-17a
(Mm00439618_m1), IL-17f (Mm00521423_m1), TGF-b (Mm00441727_g1),
IL-4 (Mm0045259_m1), IL-10 (Mm01288386_m1), RALDH1
(Mm00657317_m1), RALDH2 (Mm00501306_m1), and RALDH3
(Mm00474049_m1) were performed by use of TaqMan Universal PCR Master
Mix with 18s as an endogenous control. Relative gene expression was
calculated by use of the DD comparative threshold method with ABI Relative
Quantitation (RQ) software (Applied Biosystems).
Leukocyte isolation
Splenocytes, MLN, and ileal LP mononuclear cells were isolated, as described
previously [13, 14].
Flow cytometry
Cells from indicated compartments were incubated with fluorescently labeled
anti-mouse antibodies against: CD4 (GK1.5) and CD19 (6D5; BioLegend, San
Diego, CA, USA); CD8 (Ly-2), CCR7 (4B12), CD62L (MEL-14), CD44 (IM7),
MHCII (M5/114.15.2), CD103 (2E7), CD11b (M1/70), CD11c (N418), IFN-g
(XMG1.2), IL-17a (FFA21), CD25 (PC61.5), FoxP3 (FJK-16s), Ki67 (SolA15),
RORgt (B2D), a4b7 (DATK-32), and CCR9 (CW-1.2; eBioscience, San Diego,
CA, USA); Tbet (OX-40; BD Biosciences, San Jose, CA, USA); or
corresponding isotype controls. Intracellular staining was performed by use of
the FoxP3 staining kit (eBioscience), according to the manufacturer’s
instructions. Intracellular cytokine staining was performed following 4 h
stimulation with PMA (50 ng/ml), ionomycin (1 mg/ml), and brefeldin and
monensin. Analysis was performed by use of a BD FACSCanto II (BD
Biosciences). FACS was performed by use of a BD FACSAria III (BD
Biosciences). Further analyses were performed by use of FlowJo software
(Tree Star, Ashland, OR, USA).
Adoptive transfer studies
CD4+ TEM (CD44
highCD62Lneg) from the spleen of TNFDARE/CCR7+/+ and
TNFDARE/CCR72/2 mice were incubated with fluorescently labeled anti-
bodies, as above, and separated by use of the FACSAria system (BD
Biosciences). CD4+ effector fractions ($98% pure; 1 3 106) were suspended
in 200 mL saline and injected i.p. into 8-wk-old RAG12/2 recipients. Ilea and
colons were harvested 8 wk post-transfer, and the severity of inflammation was
assessed as described [12, 13].
CCR7 immunoblockade
Eight-week-old TNFDARE mice received 4 i.p. doses (500 mg) of anti-CCR7
mAb (Clone 4B12; R&D Systems, Minneapolis, MN, USA) or rat isotype every
4 days for 2 wk. Organs were collected 24 h after the final injection.
Statistical analysis
Statistical analyses were performed by use of ANOVA or a 2-tailed Student’s
t-test. Data were expressed as mean 6 SEM. Statistical significance was set
at P , 0.05.
RESULTS
TH1/TH17 CD4
+ TEM expressing CCR7 are increased in
MLN and ilea of TNFDARE mice with ileitis
The onset of ileitis in TNFDARE mice is characterized by marked
leukocyte infiltration of the ileum and MLN, composed pre-
dominantly of CD4+ T cells (Fig. 1A and D), most of which show
an activated effector phenotype (CD44+). Furthermore, we
phenotyped effector CD4+ from WT and TNFDARE mice and
assessed their cytokine profile by flow cytometry. Compared with
their WT counterparts, effector CD4+ from TNFDARE displayed
enhanced inflammatory cytokine production in the ileum and
draining MLN during disease onset at 8 wk of age (Fig. 1B
and E).
To begin to understand the role of CCR7 in the traffic of
effector CD4+ T cells to and from intestine during ileitis, we
assessed the mRNA expression of CCR7 in effector CD4+ T cells
from the ileum and MLN. CCR7 mRNA was increased
significantly in sorted effector CD4+ (CD44+/CD62Lneg) at 8 wk
of age (Fig. 1C and F). Thus, expression of CCR7 is not restricted
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to naı¨ve T cells, and IFN-g- and IL-17a-producing CD4+ effector
cells accumulate within the ilea and MLN of TNFDARE mice
during active disease.
CCR7 deficiency exacerbates ileitis in TNFDARE mice
Then, we generated a CCR7-deficient substrain of TNFDARE mice
and found that DARE/CCR72/2 displayed a further increase in
leukocytic infiltrate compared with its DARE/CCR71/+ counter-
parts (Fig. 2A and B). In addition, we assessed the continuum of
ileitis progression in DARE/CCR7+/+ and DARE/CCR72/2 mice
(Fig. 2C and D). Active indices revealed exacerbated ileitis at
4 wk of age (early disease) in DARE/CCR72/2 compared with its
DARE/CCR7+/+ counterparts and at 10 wk of age. A significant
increase in the chronic index was also observed at 4, 10, and
20 wk of age in DARE/CCR72/2 mice (Fig. 2C and D). The
increased leukocyte numbers in the ilea of DARE/CCR72/2
mice were accompanied by a marked increase in villus distortion
at all time-points assessed (Figure 2C and D). Thus, congenital
CCR7 deficiency exacerbated ileitis by enhancing recruitment or
by disrupting effector T cell egress from the intestine.
CD4+ TEM are retained within the ileal LP and depleted
in the MLN of DARE/CCR72/2 mice
We assessed the composition of the cellular infiltrate within
the ilea and MLN of TNFDARE/CCR72/2 and TNFDARE/
CCR7+/+ mice. Flow cytometry revealed significant reten-
tion of CD4+ (Fig. 3A) and CD8+ (Supplemental Fig. 1A)
T cells in the ilea of ΔARE/CCR72/2 . Analysis of the
draining MLN displayed a converse paucity of cellular
infiltrate in ΔARE/CCR72/2 compared with ΔARE/CCR7+/+
counterparts (Fig. 3B). Flow cytometric subanalysis revealed that
ileal retention and decreased MLN cell counts were not unique
to CD4+ but also observed for CD8+ T cells (Supplemental Fig. 1).
At 10 wk of age, DARE/CCR72/2 mice displayed a greater
accumulation of effector CD4+ (TEM) cells in the ileum
compared with TNFΔARE littermates (Fig. 3A and B). The
frequency of TCM (CD44
+/CD62L+) and TNaive (CC44
2CD62L+)
CD4+ subsets in the ilea appeared unchanged (Fig. 3A). Whereas
an increase retention of CD4+ TEM was observed in the
inflamed ilea of ΔARE/CCR72/2 mice, the MLN displayed
a significant reduction in the percentage and absolute numbers
of all T cell subsets analyzed (Fig. 3A and B). Thus, ileitis in
DARE/CCR72/2 mice is characterized by a greater
accumulation/retention of CD4+ TEM cells within intestine and
a loss of TEM, TCM, and TNaive trafficking to the draining MLN
during chronic ileitis.
CCR7 deficiency results in an altered ratio of TH1
versus TH17 CD4
+ T cells in ilea of TNFDARE mice
To understand further the specific CD4+ effector subsets that
are retained within the ileum of DARE/CCR72/2mice, we
performed a series of flow cytometry experiments on cells
isolated from the ileum and MLN. CCR7 deficiency resulted in
a marked increase in the frequency of CD4+IFN-g+ in the ileum
and MLN compared with its DARE/CCR71/+ counterparts (Fig.
4A and C). Once cytokine percentages are adjusted for the
dramatic cellularity differences associated with CCR7 de-
ficiency, the ileum and MLN of CCR7-deficient mice are
predominantly populated by IFN-g+ CD4+ T cells (Fig. 4A and
C). There is still an increase in IL-17a+ CD4+ T cells in the ileum
compared with CCR7-sufficient counterparts; however, the
magnitude of their development is reduced compared with
IFN-g+. An interesting observation is that the MLN displays
a reduction in IL-17a compared with DARE/CCR71/+ mice
(Fig. 4B and D).
Consistent with the increased retention of pathogenic
effector cells within the LP of CCR7-deficient animals was the
ileal mRNA expression of several cytokines increased in CCR7-
deficient animals (Fig. 4E, I–VI). Of note, CCR7 deficiency
results in a loss of ileal IL-17a mRNA (Fig. 4E, VII); however,
other TH17-related cytokines—IL-23 and TGF-b—displayed
a modest increase compared with TNFΔARE mice (Fig. 4E,
I–XII]. Collectively, these data provide evidence for the
generation and retention of TH1 effector CD4
+ T cells in the
terminal ileum of DARE/CCR72/2 mice.
DARE/CCR72/2 ileitis results in changes in DC
subsets, decreased expression of RALDHs, and an
imbalance in CD4+ FoxP3+ CD25+ Tregs
Previously, we have demonstrated a role for CD103+ regulatory
DC in the control of TNFDARE ileitis [15, 16]. As DCs use CCR7
to migrate to lymph nodes and educate naı¨ve CD4+ T cells
[7, 10, 17], we assessed the potential contribution of CCR7 on
DC migration by flow cytometry from DARE/CCR71/+ and
Figure 1. The onset of ileitis in TNFΔARE mice is characterized by
increased TH1/TH17 CD4
+ T cells expressing CCR7. (A and D) Cellular
composition of WT and TNFΔARE (ΔARE) ileal infiltrate and MLN, with
correlation of CD4+ and CD4+ CD44+ (TEM; CD44
high CD62Lneg) lymphocytes
by flow cytometry. (B and E) Flow cytometry analysis of CD4+ T cells from
ilea and MLN of WT and TNFΔARE mice assessing the relative expression
of IFN-g and IL-17a. Gating was performed on live, CD45+MHCIIneg CD4+
T cells from indicated compartments at 8–10 wk of age. (C and F)
Relative mRNA expression of CCR7 from sorted CD4+CD44+ from MLN
and ileum of WT and TNFΔARE mice. Data expressed as mean 6 SEM;
*P , 0.05; **P , 0.01 versus age-matched WT mice from 2 independent
experiments (n = 5 mice/strain; A and D, ANOVA; C and F, t-test).
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DARE/CCR72/2mice during peak disease. CCR7 deficiency
resulted in a significant loss of CD103+CD11b2CD11c+MHCIIhigh
DC in the ilea (Fig. 5A). mRNA expression of RALDH1,
RALDH2, RALDH3 was reduced compared with its WT
counterparts (Fig. 5B), but within the ileum, there were no
significant differences between DARE/CCR71/+ and DARE/
CCR72/2mice. In addition, there was a loss of CD103+CD11b2
DCs in the draining MLN (Fig. 5D) with a concomitant increase
in CD1032CD11b+ (Fig. 5D). Lastly, there was a marked
decrease in the expression of the RALDH enzymes RALDH2
and RALDH3 in DARE/CCR72/2 mice compared with their
DARE/CCR71/+ counterparts (Fig. 5E). Collectively, these data
highlight a critical role for CCR7 during regulatory CD103+ DC
migration and resultant loss of the RA-producing RALDH
enzymes in DARE/CCR72/2 mice.
To investigate further the downstream effect of regulatory DC
deficiency on Treg numbers in DARE/CCR7
2/2 mice, we
assessed the frequency of Treg in the ilea and MLN. During
active ileitis at 10 wk of age, DARE/CCR72/2 mice had
increased CD4+CD25+FoxP3+ Tregs in the LP compared with
TNFΔARE littermates (Fig. 5C). Conversely, the acellular MLN
of DARE/CCR72/2mice displayed a loss of CD4+CD25+FoxP3+
Treg compared with its TNF
ΔARE counterparts (Fig. 5F).
Thus, although CCR7 deficiency does not result in a failure
Figure 2. CCR7 deficiency exacerbates ileitis in TNFΔARE mice. (A and B) Cellular composition of WT, CCR72/2, TNFΔARE/CCR7+/+ (ΔARE) versus
TNFΔARE/CCR72/2 (ΔARE/CCR72/2) ileal infiltrate and MLN. (C) Histologic assessment of TNFΔARE/CCR7+/+ and TNFΔARE/CCR72/2 mice ilea at
indicated ages, according to acute and chronic leukocytic infiltrates, villus distortion, and a combinatorial total inflammatory index. (D) Representative
micrographs of ileum H&E from TNFΔARE/CCR7+/+ and TNFΔARE/CCR72/2 mice between 4 and 20 wk of age. Data expressed as mean 6 SEM;
*P , 0.05; **P , 0.01 versus age-matched WT mice (n = 10–18 mice/strain, ANOVA). Original scale bars, 100 mm.
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to induce FoxP3+ T cells, it appears to impair their ability
to migrate to the MLN.
Anti-CCR7 mAb augments a TH1 cytokine profile,
reduces CD103+ DC subsets, and exacerbates ileitis in
TNFΔARE mice
To assess the effects of CCR7 immunoblockade, we administered
a neutralizing anti-CCR7 mAb or corresponding isotype control
to 8-wk-old TNFΔARE mice. We have shown previously that similar
to the observation in genetic CCR7 deficiency, CCR7 mAb
immunoblockade exacerbated TNFΔARE ileitis significantly, as
indicated by increased infiltration of the terminal ileum and
a paucity of leukocytes within the MLN [9]. Furthermore, anti-
CCR7 mAb exacerbated all histologic indices significantly
compared with vehicle controls (Fig. 6A). When compared with
its TNFΔARE counterparts, CCR7 deficiency augments an ileal
TH1 cytokine profile (Fig. 6B) but did not alter the expression of
ileal IL-17a, IL-17f, or IL-23 (Fig. 6B).
As with congenital CCR7 deficiency, CCR7 blockade resulted in
a significant loss of CD103+CD11b2CD11c+MHCIIhigh DC in the
ilea compared with its WT counterparts (Fig. 6C and D). Thus,
antibody blockade of CCR7 in TNFΔARE ileitis inhibited lympho-
cyte egress, promoted a TH1 cytokine profile, decreased
RA-producing DCs, and exacerbated intestinal inflammation.
CCR7-deficient CD4+ TEM induce ileo-colitis in
RAG12/2 mice
We have reported previously that CD4+ TEM drive ileitis in
TNFΔARE mice [13]. As such, we assessed whether CCR7
deficiency altered the capacity of effector CD4+ from TNFΔARE
mice to transfer ileitis adoptively into lymphopenic recipients. To
address this, effector CD4+ were isolated from spleens of 4- to
6-wk-old DARE/CCR7+/+ and DARE/CCR72/2 mice and adop-
tively transferred separately into RAG12/2 recipients. Of note,
DARE/CCR7+/+ and DARE/CCR72/2 CD4+ CD44+ T cells
expressed comparable pretransfer levels of transcription factors,
such as FoxP3, Tbet, and RORgt. This was also evident for the
intestinal homing markers a4b7 and CCR9, in addition to
cytokines IFN-g, TNF, and IL-17a (Supplemental Fig. 2). Eight
weeks post-transfer, CCR7-deficient effector CD4+ T cells were
retained in the ileum and colon, with a paucity of adoptively
transferred T cells in the draining MLN (Fig. 7B). Surprisingly,
flow cytometry assessment of Ki67+ in proliferating CD4+ T cells
in the ilea and colon revealed no appreciable difference in the
relative percent of Ki67+ from either genotype (DARE/CCR7+/+
vs. DARE/CCR72/2; ileum, P = 0.480; colon, P = 0.864; Fig. 7C
and D). This was also evident for the transcription factors Tbet
(P = 0.444) and RORgt (P = 0.112; Fig. 4E). Of note, however,
DARE/CCR72/2 CD4+ T cells developed a predominant TH1
Figure 3. CCR7 deficiency increased ileal retention
of CD4+ TEM and inhibits egress to draining MLN.
(A) Flow cytometric analyses characterizing the
absolute cell numbers of TEM, TCM, and TNaive CD4
+
T cells in the ilea and MLN of WT, CCR72/2,
DARE1/1 and DARE2/2 mice. (B) Representative
flow cytometry contour plots depicting frequency
of TEM, TCM, and TNaive CD4
+ T cells in the ilea
and MLN of DARE/CCR71/1 or DARE/CCR72/2
and WT mice. Data expressed as mean 6 SEM;
**P , 0.01 versus its indicated counterpart from
3 independent experiments (n = 6 mice/strain,
ANOVA).
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profile with a loss of TH17, similar to effects with congenital
CCR7 deficiency (Fig. 7F–I). In addition, mice adoptively
transferred with CCR7-deficient effector CD4+ displayed signifi-
cantly exacerbated histologic parameters of ileitis and colitis
compared with CCR7-sufficient controls (Fig. 7J and K). Of note,
whereas effector CD4+ from DARE mice adoptively transferred
ileitis, CCR7-deficient CD4+ cells induced a dysregulated ileo-
colitis in RAG12/2 mice (Fig. 7J and K). Collectively, these data
underscore a critical and previously unappreciated role for CCR7
in the regulation of small intestinal T cell development, intestinal
retention, and lymphatic recirculation.
CCR7 deficiency in TNFΔARE mice induces multiorgan
inflammation and associated pathology
Whereas pathology is restricted to the terminal ileum in
TNFΔARE/CCR7+/+ during active disease at 8 wk of age, we sought
to assess if the exacerbated inflammation observed in TNFΔARE/
CCR72/2 mice allowed for a loss of peripheral tolerance and
the development of extraintestinal manifestations. Indeed
a multiorgan inflammation and panenteritis were also observed
by 8 wk of age in the DARE/CCR72/2mice (Fig. 8A). With the
exception of solid organs, such as the brain and kidney, CCR7
deficiency resulted in a marked inflammatory infiltrate in all
Figure 4. Altered TH1/TH17 CD4
+ ratio in ΔARE/
CCR72/2 mice. (A–D) Absolute numbers and
representative flow cytometry plots of IFN-g+ versus
IL-17a+ from ileum and MLN CD4+ T cells. Gating
was performed on live, CD45+ MHCIIneg CD4+
T cells at 8–10 wk of age. Data expressed as mean 6
SEM; **P , 0.01 versus age-matched indicated
counterparts from 2 independent experiments
(t-test). (E, I–XII) Cytokine mRNA analysis was
performed by real-Time PCR on ileal tissues from
CCR7-sufficient or -deficient WT and ΔARE/CCR71/1
or ΔARE/CCR72/2 mice at 10 wk of age. Data
expressed as mean 6 SEM; *P , 0.05; **P , 0.01
versus indicated counterparts from 2 independent
experiments (n = 6 mice/strain, ANOVA).
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mucosal sites and a panenteritis of the gastrointestinal tract
(Fig. 8A and B). The extent of multiorgan inflammation is
also evident from macroscopic assessment at necropsy, where
DARE/CCR72/2mice display a clear inability to thrive by 8 wk
of age (Fig. 8C). Thus, these data are consistent with an
absolute requirement for CCR7 in cellular egress out of
intestinal tissues and highlight its critical role in controlling
intestinal homeostasis.
Figure 5. Changes in CD103+ versus CD11b+ DC subsets, loss of RALDH enzymes, and altered Treg profile in ΔARE/CCR72/2 mice. (A) Frequency of
ileal CD103+ and CD11b+ DC population and representative flow cytometry plots of ileal CD103+ and CD11b+ DC. SSC-A, Side-scatter-area. (B) Relative
mRNA expression analysis of ileal RALDHs (RALDH1, RALDH2, RALDH3) from indicated genotypes. (C) Absolute numbers of CD4+CD25+FoxP3+
Tregs from the ileum of CCR7-sufficient or -deficient WT and ΔARE/CCR71/1 or ΔARE/CCR72/2 mice. (D) Frequency of MLN CD103+ and CD11b+
DC population. (E) Relative mRNA expression analysis of RALDHs (RALDH1, RALDH2, RALDH3) in the MLN from indicated genotypes. (F) Absolute
numbers of CD4+CD25+FoxP3+ Tregs from the MLN of CCR7-sufficient or -deficient WT and ΔARE/CCR71/1 or ΔARE/CCR72/2 mice. Experiments
were performed from indicated compartments and genotypes at 8–10 wk of age. Data expressed as mean 6 SEM from 3 independent experiments;
*P , 0.05; **P , 0.01 (n = 4–6 mice/strain, ANOVA).
Figure 6. Antibody blockade of CCR7 exacerbates ileitis in TNFDARE mice by inhibiting lymphatic egress and promoting retention of effector/memory
CD4+ T cells. Eight-wk-old TNFΔARE mice received 4 injections (i.p.) of anti-CCR7 (4B12; 500 mg) or IgG2a vehicle every 4 days for 2 wk. (A) Histology
indices were assessed for ileal tissue post-treatment with representative micrographs. (B) Cytokine mRNA analysis was performed by real-time PCR on
ileal tissues of isotype (IgG2a)- and anti-CCR7-treated mice. (C) Frequency of CD103+ and CD11b+ DC subsets from ilea post-treatment. Data expressed
as mean 6 SEM; *P , 0.05; **P , 0.01 versus IgG2a from 2 independent experiments (n = 6–7 mice/treatment). (A and B) t-test versus IgG2a; (C)
ANOVA). Original scale bars, 100 mm.
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Figure 7. CCR7-deficient CD4+ effector T cells from TNFDARE mice drive a dysregulated ileo-colitis following adoptive transfer into RAG12/2 mice.
CD4+ TEM (CD44
high CD62Lneg) from the spleen of 4- to 6-wk-old DARE/CCR7+/+ and DARE/CCR72/2 mice were isolated by FACS and adoptively
transferred (1 3 106; i.p.) into RAG12/2 recipients. (A) Representative assessment of CCR7 on adoptively transferred CD4+ T cells by flow cytometry.
(B) Cell counts were assessed 8 wk post-transfer in ilea, colon, and MLN. (C and D) Percentage of Ki67+ in proliferating CD4+ T cells in the ilea and colon
and representative flow cytometry plots from the ileum. (E) Representative flow cytometry histograms of ileal Tbet+ and RORgt+ CD4+. MFI, Mean
fluorescence intensity. (F and G) Percentage of ileal IFN-g+ CD4+ T cells and representative flow cytometry plots. (H and I) Percentage of colonic IL-17a+ CD4+
and representative flow cytometry plots. (J and K) Total inflammatory indices from adoptively transferred RAG12/2 recipient ilea and colons. Data
expressed as mean 6 SEM; *P , 0.05; **P , 0.01 versus DARE/CCR7+/+ from 2 independent experiments (n = 6–7 mice/treatment). (B, J, and K, t-test;
F and H, ANOVA). Original scale bars, 100 mm.
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DISCUSSION
With the recent U.S. Food and Drug Administration-approval of
Vedolizumab, the targeting of leukocyte traffic to the intestine
has become the next frontier for the treatment of IBD [18, 19].
Natalizumab and Vedolizumab target one of many potentially
“drugable” steps within the lymphocyte adhesion cascade; thus,
we may envision that additional molecular targets will be
identified within this pathway. It is likely that in IBD, there is not
only excessive recruitment of proinflammatory TEM to the
intestine but also, disproportionate retention within the LP
that perpetuates the chronic inflammatory process. Whereas
dysregulated recruitment of effector TH1/TH17 CD4
+ has been
implicated in driving disease in CD [20, 21], the specific
determinants that control its retention within the intestine and
egress through lymphatics remain poorly understood. In this
regard, CCR7 serves as a master rheostat for T cell responses, as it
guides mature antigen-presenting DCs and naı¨ve T cells to and
within lymphoid organs [22]. However, to date, a role for CCR7
in controlling the T cell retention/egress under intestinal
homeostasis and inflammation remains poorly defined.
A central dogma had been that homing of cytokine-producing
effector CD4+ T cells to nonlymphoid tissues and their sub-
sequent egress was independent of CCR7, a molecule expressed
predominantly by naı¨ve T cells to traffic to secondary lymphoid
organs [23, 24]. More recent data have challenged that theory
and identified a clear ability of cytokine-producing CD4+ T cells
to use CCR7 for lymphatic egress and recirculation [4, 5, 25]. We
have demonstrated previously that CD4+ TEM subsets are crucial
for driving the chronic phase of ileitis in the TNFΔARE model, as
evidenced by adoptive-transfer studies in lymphopenic mice
[13, 26]; additionally, our data have indicated that LP CD8+
T cell subsets play a redundant role in the pathogenesis of ileitis
(contrary to previously published reports [27]) but are critical for
the T cell-mediated immunoregulation of disease [26]. Whereas
CD8+ T cell and CD19+ B cell subsets can express CCR7 to
varying degrees [9] and are dysregulated by the loss of CCR7 in
TNFΔARE (Supplemental Fig. 1), based on our data that show
maximal retention of CD4+ TEM subsets and our previous work
implicating this subset in disease pathogenesis [13], we focused
here on understanding the regulation of CD4+ TEM by CCR7.
In an attempt to discriminate CD4+ TEM ileal retention and
lack of lymphatic egress from dysregulated TH1/TH17/Treg
polarization with CCR7 deficiency, we performed a series of
adoptive-transfer experiments with CCR7-deficient effector
T cells into lymphopenic RAG12/2 mice. Whereas CD4+CD44+
TEM from TNF
ΔARE adoptively transferred disease, DARE/
CCR72/2 TEM displayed exacerbated ileitis in addition to
dysregulated colitis. Consistent with our data with congenital
CCR7 deficiency, transfer of CCR7-deficient CD4+ TEM promoted
a marked generation and retention of TH1 within the ileum and
impaired egress to the MLN. This raises the question as to why
there is a predominant TH1 profile in DARE/CCR7
2/2 and
a paucity of TH17. Recent work, assessing the anatomic locations
responsible for the homeostatic proliferation of gut-homing
a4b7+ CD4+ T cells, has shown that fast-dividing, gut-homing
CD4+ T cells were composed predominantly by an IL-17a+-
producing cohort in the MLN and ileum, whereas splenic-
derived, fast-dividing CD44+ CD4+ T cells were mainly composed
of IFN-g+ [28]. Whereas this is not surprising, given the recent
identification of the small intestine as the major site for TH17
development [29, 30], it would suggest that splenic (or
“peripherally”)-derived IFN-g+ CD4+ T cells override this
anatomic divide when CCR7-mediated trafficking to the MLN is
lost. This was implicated further when mice devoid of a MLN fail
to develop a TH17 response, but IFN-g
+ CD4+ T cells are
unaffected [28]. Indeed, a TH1 profile has been observed in
CCR7-deficient mice with gastritis after 1 yr [31]. However, based
on our data that show no measurable difference in the levels of
Ki67+ proliferation in gut-homing, CCR7-deficient CD4+ T cells
and previous data showing no appreciable loss of colitogenic
Figure 8. ΔARE/CCR72/2 mice induce multiorgan
inflammation and associated pathology. (A) His-
tologic assessment and pathologic evaluation of
ΔARE/CCR71/+ and ΔARE/CCR72/2 mice at
10 wk of age. (B) Representative micrographs of
tissue H&E from ΔARE/CCR71/+ and ΔARE/
CCR72/2 mice. (C) Representative macroscopic
assessment at necropsy of ΔARE/CCR72/2 mice
displays a clear inability to thrive by 8 wk of
age. Data expressed as mean 6 SEM; *P , 0.05;
***P , 0.001 versus age-matched ΔARE/CCR71/+
counterparts (n = 3–5 mice/strain, t-test). Original
scale bars, 100 mm.
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CD4+ T cells in mice deficient in spleen and MLN [32, 33],
altered proliferation/differentiation of TH1 may not fully explain
our DARE/CCR72/2 phenotype. Indeed, increased TH1-medi-
ated chemotaxis may augment this pathology, based on our data
showing increased “TH1” chemokines in DARE/CCR7
2/2 mice
during peak disease. Whereas not assessed in this study,
increased survival signals for TEM, such as IL-2, IL-7, and IL-15,
may also predominate the DARE/CCR72/2 ileum.
One other possible reason for the dysregulated retention/
egress of TH1 CD4
+ in DARE/CCR72/2 ileitis may be mediated
by effects on DCs, which use CCR7 to home to lymph nodes and
educate naı¨ve CD4+ T cells [7, 10, 17]. Indeed, recent clinical
data have reported altered cytokine profiles and T cell-
generating capacities of MLN DCs from patients with IBD [3]. A
subset of intestinal DC [defined by their expression of CCR7
and integrin aE (CD103)] produces RA and in the presence of
TGF-b, promotes the induction of Tregs [34]. This CD103
+ DC
subset expresses high levels of RALDH2, an enzyme critical to
metabolizing retinaldehyde to RA [34]. We have demonstrated
previously that expansion of CD103+ regulatory DCs by Flt3L or
exogenous supplementation of RA attenuates ileitis in TNFΔARE
mice [15, 16]. As such, it is worth noting that the TNFΔARE mouse
model (as with human CD) is highly responsive to imbalances in
regulatory DC and Treg populations. In addition to the
generation and retention of TH1 CD4
+ T cells and heightened
ileitis in DARE/CCR72/2mice, we observed reduced numbers of
CD103+ regulatory DCs in the ilea and MLN during active ileitis.
As CD103+ DC drives the generation of Treg in GALT [34, 35], it
is very plausible that the observed reduction in RALDH2 and
RALDH3 enzymes, in addition to CD25+ FoxP3+ Tregs in the MLN
of DARE/CCR72/2, compounds their dysregulated inflamma-
tion. However, one point to note is that whereas CCR7+ CD103+
DCs are indeed critical for generating Tregs and CCR9
+ a4b7+
gut-homing T cells, they do not affect the relative expression of
IFN-g+ production from antigen-specific CD8+ T cells. This is
evidenced by data showing that OVA-specific OT-I CD8+ T cells
show similar proliferation and generation of IFN-g+ effectors
regardless of whether they are stimulated with CD1032 or CD103+
DCs [36]. Currently, whereas commensal segmented filamentous
bacteria have been implicated in inducing gut-homing TH17
[28, 30, 37], the factors controlling intestinal-specific TH1 are
less well defined.
The predominant TH1 profile in DARE/CCR7
2/2 mice seems
somewhat discrepant from previous reports of T cell profiles in
other organs. Specifically, CCR7-deficient CD4+ T cells secrete
IL-4 preferentially and potentiate an allergic asthma with
elevated IL-4, IL-13, and IgE [17, 38]. Conversely, CCR7 signaling
via CCL21 on T cells drives a TH1-favorable response via
increased IFN-g [39]. In addition, CCL19 and CCL21 induce the
TH1-polarizing cytokine IL-12 from DCs [40]. These data point
toward a context-, tissue-, and stimuli-dependent role for CCR7 in
controlling TH responses. It is worth noting that a microbial
dysbiosis has been identified in a TNFΔARE model of CD [41].
Antibiotic-induced dysbiosis also results in a marked trans-
location of noninvasive commensal bacteria to the draining MLN
with an increased preference for the production of IFN-g [42].
Thus, it is plausible that the dysregulated, TH1-driven
inflammation in DARE/CCR72/2 mice is mediated, in part, by
a lack of CD103+ DC/Treg-mediated tolerance in the draining
MLN and/or a heightened bacterial influx.
A striking phenotype of the DARE/CCR72/2 mice is
a widespread multiorgan inflammation and panenteritis, which
these mice develop after weaning. Whereas TNFΔARE mice
display pathology restricted to the ileum, CCR7 deficiency
renders T cells unable to recirculate, “log jamming” within
effector sites and driving dysregulated multiorgan inflammation.
Of note, multiorgan inflammation has been reported in older,
CCR7-deficient mice [31, 43]; however, our data emphasize the
nonredundant role that lymphocyte egress/retention signals
have on the early events leading to induction of chronic
intestinal inflammation. These data also underscore the critical
role played by CCR7 in orchestrating peripheral tolerance and
self-reactivity [31, 44, 45]. Whereas FoxP3+ CD4+ Tregs are
increased in the ilea of DARE/CCR72/2 mice, they are devoid in
the MLN compared with their DARE/CCR71/+ counterparts.
Thus, it is also plausible that dysregulated generation of CD4+
TEM in the MLN and defective control of those T cells by Tregs
may explain the augmented ileitis observed in DARE/CCR72/2
mice. Tregs play a crucial role in the homeostatic proliferation of
gut-homing T cells, in addition to suppressing the development
of colitogenic T cells in an OX40/OX40 ligand-dependent
manner [28, 46]. Indeed, aberrant lung inflammation in CCR7-
deficient mice was also abrogated following adoptive transfer of
WT Tregs [47]. Furthermore, as cytokines produced by CD4
+
effector T cells also regulate diverse functions within peripheral
lymph nodes, such as Ig class-switching and B cell help,
regulation of T cell differentiation, and DC cross-talk, the paucity
of CD4+ TEM in the MLN of CCR7-deficient mice may further
exacerbate the lack of immunoregulation during ileitis in
TNFΔARE mice via multiple mechanisms.
Recent data have suggested that during the course of an
inflammatory insult in the skin, CCR7 plays a crucial role during
the acute phase but is redundant in controlling lymphocyte
egress during chronic inflammation [48]. A redundant role for
CCR7 was also observed during induction of autoimmune
encephalitis and allergic asthma [49, 50]. In discordance with
these observations, our data point toward a critical role for CCR7
in regulating the balance between TEM retention versus
lymphatic egress and highlight the importance of homeostatic
lymphatic function in the intestinal mucosa. This may also
underscore the differences observed between inducible injury
models of inflammation (e.g., Dextran sodium sulfate) and the
chronic inflammation that drives ileitis in TNFΔARE mice and
human IBD. However, a question remains regarding the
exclusive requirement of CCR7 for the homing of T cells to
lymph nodes. Both our current data and previous literature
[17, 48] indicate that T cells are not completely absent from the
lymph nodes of CCR7-deficient mice, suggesting compensatory
or overlapping machinery used by T cells to home to draining
lymph nodes under homeostatic and inflammatory conditions.
Whereas alternative chemokine or selectin receptor-ligand
systems may be responsible (e.g., CXCR4-CXCL12, CXCR3-
CXCL9/CXCL10, and L-selectin-peripheral node addressin),
this remaining population of T cells may also be representative of
lymph node follicular TH. Furthermore, whereas T cells have the
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capacity to alter their chemokine receptor profile to migrate into
peripheral tissues [51, 52], the molecular machinery and specific
stimuli, which induce CCR7 expression, remain to be
determined.
Whereas the therapeutic blockade of CCR7 for the prevention
of aberrant T cell response to self-antigen in peripheral lymph
nodes may have held interest for autoimmune diseases, such as
type 1 diabetes [44, 53], or the prevention of lymphatic
metastasis in some cancers [54], our data stress a critical role for
this chemokine receptor in orchestrating T cell and DC
recirculation during murine ileitis and argue against CCR7
blockade as a target for the treatment of IBD.
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